XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 64 filers reported holding XBIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -23.1% | 1,143 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -13.3% | 1,143 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $15,000 | -21.1% | 1,143 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,000 | -5.0% | 1,143 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $20,000 | +11.1% | 1,143 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $18,000 | -18.2% | 1,143 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $22,000 | +37.5% | 1,143 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $16,000 | +33.3% | 1,143 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | -57.1% | 1,143 | -22.5% | 0.00% | 0.0% |
| Q4 2019 | $28,000 | +86.7% | 1,474 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | +36.4% | 1,474 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | +57.1% | 1,474 | +8.2% | 0.00% | – |
| Q1 2018 | $7,000 | +40.0% | 1,362 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -16.7% | 1,362 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | 0.0% | 1,362 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -72.7% | 1,362 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $22,000 | – | 1,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,872 | $273,000 | 0.12% |
| WINTON GROUP Ltd | 16,373 | $281,000 | 0.02% |
| CAXTON ASSOCIATES LP | 10,309 | $177,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 58,047 | $997,000 | 0.01% |
| ALPS ADVISORS INC | 52,932 | $909,000 | 0.01% |
| McIlrath & Eck, LLC | 753 | $13,000 | 0.01% |
| Russell Investments Group, Ltd. | 119,464 | $2,050,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 8,963 | $152,000 | 0.00% |
| ExodusPoint Capital Management, LP | 12,811 | $220,000 | 0.00% |
| SYNOVUS FINANCIAL CORP | 11,796 | $203,000 | 0.00% |